Related Experiment Videos
Preparation, characterization and protein loading of hexanoyl-modified chitosan nanoparticles.
Kashappa Goud Desai1, Hyun Jin Park
1School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Drug Delivery
|August 1, 2006
Summary
Researchers developed hexanoyl chitosan nanoparticles for drug delivery. These nanoparticles demonstrated effective encapsulation of bovine serum albumin, showing potential for therapeutic applications.
Area of Science:
- Materials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Chitosan is a biocompatible and biodegradable polysaccharide with vast applications.
- Modifying chitosan can enhance its properties for specific uses, such as drug delivery systems.
Purpose of the Study:
- To synthesize and characterize hexanoyl chitosan.
- To prepare and analyze hexanoyl chitosan-tripolyphosphate (TPP) nanoparticles.
- To evaluate the encapsulation efficiency and loading capacity of these nanoparticles for bovine serum albumin (BSA).
Main Methods:
- Hexanoyl chitosan was synthesized via coupling reaction with hexanoic anhydride.
- Proton nuclear magnetic resonance (1HNMR) and Fourier-transform infrared (FTIR) spectroscopy confirmed synthesis.
- Ionotropic gelation with TPP followed by sonication was used to form nanoparticles.
- Atomic force microscopy (AFM) and transmission electron microscopy (TEM) characterized nanoparticle morphology.
- Encapsulation efficiency and loading capacity were determined at varying BSA concentrations.
Main Results:
- Successful synthesis of hexanoyl chitosan was confirmed by spectroscopic analysis.
- Hexanoyl chitosan-TPP nanoparticles displayed a uniform spherical shape and smooth surface.
- Particle size ranged from 54.1 to 724 nm, with a mean diameter of 324 nm.
- Encapsulation efficiency decreased from 58.2% to 28.1% as BSA concentration increased.
- Loading capacity increased from 14.1% to 30.3% with increasing BSA concentration.
Conclusions:
- Hexanoyl chitosan-TPP nanoparticles are successfully synthesized and characterized.
- The nanoparticles exhibit suitable morphology and size for potential drug delivery applications.
- The study demonstrates the capacity of these nanoparticles for BSA encapsulation, with loading capacity increasing at higher concentrations.